Donate
Call the Lung HelpLine
Ask a Question
The following text field filters the results that follow as you type. Use Tab to access the results.
  1. Home
  2. Research & Reports
  3. About Our Research
  4. Meet the Researchers
  5. Scott Matson, MD
Scott Matson, MD

Scott Matson, MD

University of Kansas Medical Center Research Institute, Inc.

Research Project:
Identifying Metabolic Changes in Early-Stage Pulmonary Fibrosis

Grant Awarded:

  • Dalsemer Interstitial Lung Disease Award

Research Topics:

  • biomarkers
  • computational biology

Research Diseases:

  • interstitial lung disease
  • pulmonary fibrosis

Idiopathic pulmonary fibrosis is a progressive scarring lung disease that leads to significant morbidity and poor survival. There are treatments for pulmonary fibrosis, however they only slow lung function decline. Patients often are diagnosed only after they have advanced disease, when the benefit of treatment is limited. Understanding molecular changes in patients with pulmonary fibrosis before they start showing symptoms is critical to improving outcomes. Early forms of pulmonary fibrosis are identified on screening computed tomography (CT) scans of the chest. They are associated with worse survival and progression to pulmonary fibrosis with symptoms. We plan to study more than 7,000 subjects to study metabolomic changes that are associated with these CT scan patterns. Our goal is to identify important markers and pathways associated with pulmonary fibrosis risk.

Dalsemer Interstitial Lung Disease Award

Page last updated: November 22, 2024

Implementation and Interpretation of Spirometry
Belgrade, MT | Dec 05, 2024 Freedom From Smoking Clinic
Manchester, CT | Jan 06, 2025
See All Events